Discover how Monte Carlo analysis helps investors assess risk and make informed decisions. Explore its role in generating ...

Identifying risk factors enables physicians to implement targeted intervention strategies and preventive measures, aiming to reduce the disease burden and minimize the risk of relapse. Multiple ...

An international study has used a computational biology tool that, by analyzing a multitude of biological data from multiple sclerosis patients ranging from genetic information to the whole organism, ...

Mendelian randomization revealed a significant link between higher genetically-determined BMI and increased MS severity, strengthening previous observational findings. Expanded analysis included ...

The CD40–CD40L costimulatory pathway regulates adaptive and innate immune responses and has been implicated in the pathogenesis of multiple sclerosis. Frexalimab is a second-generation anti-CD40L ...

Comparison of IMWG and PANGEA risk models predicting MGUS to multiple myeloma progression in a safety net hospital. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...

Daratumumab, a monoclonal antibody targeting CD38, has been approved for use with standard myeloma regimens. An evaluation of subcutaneous daratumumab combined with bortezomib, lenalidomide, and ...